Lv11
80 积分 2026-01-29 加入
Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies
2小时前
待确认
Assessing the role of radiotherapy in patients with refractory or relapsed high-grade B-cell lymphomas treated with CAR T-cell therapy
5天前
已完结
Radiotherapy in primary central nervous system lymphoma: Evolution of its role and current position in combined treatment strategies
19天前
已完结
Anti‐CD19 CAR T‐cell therapy for patients with Richter transformation: A LYSA study from the DESCAR‐T registry
20天前
已完结
Efficacy and Safety of Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed and Refractory AL Amyloidosis
20天前
已完结
Richter's transformation: Transforming the clinical landscape
21天前
已完结
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma
21天前
已完结
The Evolving Therapeutic Landscape of Richter Transformation
21天前
已完结
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
24天前
已完结
Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study
24天前
已完结
皖公网安备34019202002308
